LABORATORY AND DIAGNOSIS

Blood unit screnning

DIAGNOSTIC DATE ORDERED PURPOSE RESULT ANALYSIS AND NURSING
LABORATORY TEST INTERPRETATION RESPONSIBILITIES
Blood unit 9/19/23 The purpose of blood Malaria NONREACTIVE
screnning screening is to HBsAG NONREACTIVE
evaluate the overall Anti-HCV NONREACTIVE
health and detect HIV COMBO NONREACTIVE
potential medical Syphylis NONREACTIVE
conditions or
diseases in individual.

HEMATOLOGY

DIAGNOSTIC DATE ORDERED PURPOSE RESULT ANALYSIS AND NURSING

LABORATORY TEST INTERPRETATION RESPONSIBILITIES
Hematology 9/15/23 The purpose of WBC Count -3.29 Abnormal 1. Monitoring and
hematology is to Normal assessment: Regularly
Neutrophils- 37.1
study and monitor the patient's
understand blood Lymphocytes- 54.6 Normal vital signs, including
and its temperature, heart
Monocytes-7.1 rate, blood pressure,
components, Normal
and oxygen saturation.
specifically focusing Eosinophils-0.7 Normal
Assess the patient's
on blood cells and overall condition,
Basophils- 0.5
their related Normal looking for signs of
disorder. RBC Count-2.82 Abnormal infection, fatigue,
Hematology plays a weakness, shortness of
crucial role in HEMOGLOBIN (Hgb) Abnormal breath, or bleeding.
- 9.0
 diagnosing and HEMATOCRIT (Hct) - 2. Reporting and
treating various 25.2 Documentation:
condition related to Abnormal Document the
MCV- 89.2 patient's baseline and
blood and its
ongoing laboratory
cellular elements. MCH- 31.9 Normal
values, including WBC
MCHC- 35.8 count, hemoglobin,
Normal hematocrit, and
PLATELET- 77 Normal platelet levels. Report
any significant changes
Abnormal or abnormal results to
the healthcare team
WBC Count -2.95 promptly.
3. Precautionary
09/17/ 23 Neutrophils- 48.0 Abnormal measures: Implement
Normal infection control
Lymphocytes- 43.0
measures to prevent
Monocytes-6.0 the spread of
Normal
infections. These may
Eosinophils-2.2 Normal include hand hygiene,
isolation precautions,
Basophils- 0.8 Normal and appropriate use of
RBC Count-2.71 Normal personal protective
equipment (PPE) when
HEMOGLOBIN (Hgb) Abnormal necessary.
- 8.4 4. Preventing
Abnormal complications: Low
HEMATOCRIT (Hct) - WBC count puts
23.3 patients at higher risk
Abnormal
of infection. Educate
MCV- 86.1
the patient and their
Normal caregivers about
MCH- 31.0
proper hygiene
MCHC- 36.0 Normal practices, such as
 PLATELET- 45 Abnormal regular handwashing,
Abnormal avoiding crowded
places, and staying
WBC Count -3.92 away from individuals
who are sick.
Neutrophils- 37.4 5. Administering
09/18/23 Normal
medications and
Lymphocytes- 52.6 Abnormal treatments: As
Monocytes-7.4 directed by the
Abnormal healthcare team,
Eosinophils-2.0 Normal administer prescribed
medications to address
Basophils- 0.6 Normal specific needs. For
RBC Count-3.67 Normal example, if the patient
has low WBC count,
HEMOGLOBIN (Hgb) Abnormal they may require
- 11.4 colony-stimulating
Abnormal
factors to boost white
HEMATOCRIT (Hct) - blood cell production.
31.2 If the patient's
Abnormal hemoglobin level is
MCV- 85.1
low, they may need
MCH- 31.2 Normal blood transfusions or
iron supplements.
MCHC- 36.6 Normal 6. Monitoring for
bleeding: Low platelet
PLATELET- 39
Abnormal levels can increase the
Abnormal risk of bleeding.
Observe the patient for
signs of bruising,
petechiae (small,
pinpoint red or purple
WBC Count -4.49 spots), or excessive
bleeding from wounds.
09/19/23 Neutrophils- 37.3 Normal Take appropriate
measures to prevent
Lymphocytes- 49.1 injuries, such as using a
Abnormal
Monocytes-9.4 Normal soft-bristle toothbrush
and avoiding activities
Eosinophils-3.4 that may cause
Normal
trauma.
Basophils- 0.8 Normal
RBC Count-3.68
Normal
HEMOGLOBIN (Hgb) Abnormal
- 11.2
Abnormal
HEMATOCRIT (Hct) -
31.3 Abnormal
MCV- 85.1

MCH- 30.5 Normal

MCHC- 35.8 Normal

PLATELET- 42 Abnormal
Abnormal

WBC Count -5.14

Normal
Neutrophils- 34.7
09/20/23
Lymphocytes- 52.6 Abnormal
Abnormal
Monocytes-9.4

Eosinophils-2.8 Normal
Basophils- 0.5
Normal
 RBC Count-3.26 Normal
HEMOGLOBIN (Hgb)
Abnormal
- 10.2
Abnormal
HEMATOCRIT (Hct) -
27.7
Abnormal
MCV- 85

MCH- 31.3 Normal

Normal
MCHC- 36.8

PLATELET- 55 Abnormal

Abnormal

CLINICAL CHEMISTRY

DIAGNOSTIC DATE ORDERED PURPOSE RESULT ANALYSIS AND NURSING

LABORATORY TEST INTERPRETATION RESPONSIBILITIES
Clinical Chemistry 09/10/23 The purpose of clinical Creatinine- 119 Abnormal 1. Monitoring and
chemistry is to Sodium- 125.7 Abnormal assessment: Regularly
measure and analyze Potassium- 4.34 Normal monitor the patient's
various substances, RBS- 232 Abnormal vital signs, including
such as electrolytes, blood pressure, heart
enzymes, hormones, rate, respiratory rate,
lipids, carbohydrates, and temperature. Keep
proteins, and other an eye out for
metabolites present in symptoms such as
the body's fluids, decreased urine
including blood and output, dehydration,
 urine. It helps confusion, weakness,
healthcare and signs of fluid
professionals assess a overload.
patient's overall health,
2. Reporting and
diagnose diseases,
documentation:
monitor treatment
Document the
effectiveness, and
patient's baseline and
manage conditions.
ongoing laboratory
values, including
creatinine levels,
09/19/23 Sodium- 135.4 Normal sodium levels, and
blood sugar levels.
Report any significant
changes or abnormal
results to the
healthcare team
promptly.

3. Fluid and
electrolyte
management: Work
closely with the
healthcare team to
develop an appropriate
plan to address the
imbalance. Follow
orders for fluid
restriction, diuretic
administration, or fluid
replacement, as
indicated. Monitor
intake and output
closely and ensure
accurate measurement
of fluids.

4. Addressing
hyperglycemia: If the
patient's blood sugar
levels are high, work
with the healthcare
team to initiate or
adjust insulin therapy if
necessary. Monitor
blood sugar levels
regularly and educate
the patient and their
caregivers on proper
dietary management
and medication
administration.

5. Renal function
monitoring: Ensure the
patient is receiving
adequate hydration
and follow any dietary
restrictions related to
kidney function.
Monitor urine output
and quality to identify
potential changes in
renal function
promptly.
Clinical Microscopy

DIAGNOSTIC DATE ORDERED PURPOSE RESULT ANALYSIS AND NURSING

LABORATORY TEST INTERPRETATION RESPONSIBILITIES
Urine 09/016/23 Color- yellow
Transparency- slighlty
turbid
Ph-5.0
Specific gravity- 1.020

Chemical Test Albumin- trace

Sugar- Negative

Cells Pus Cell- 0-2/HPF

Rbc- 3-7/HPF
Epithelial Cell- few

Crystal Amorphous- Abundant

XRAY REPORT

DIAGNOSTIC DATE ORDERED PURPOSE RESULT ANALYSIS AND NURSING

LABORATORY TEST INTERPRETATION RESPONSIBILITIES
Chest PA 09/016/23 The purpose of a - There are no Atheromatous aorta
Chest PA parenchymal
(posteroanterior) X- infiltrates in both
ray is to evaluate the lung fields
structures and
- the heart is not
conditions of the
enlarged
chest, including the
lungs, heart, bones, - Aorta is tortous and
and other calcified
surrounding tissues.
It is one of the most - chest wall,
commonly performed hemidiaphragms,
diagnostic imaging costophernic sulci
tests and serves and visualized bones
several important are intact.
purposes:
ECG